Company Overview and News
7h sec.gov - 1
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
I’m a big proponent of using share building accounts to build up positions in companies over time. There are many companies that will even let you do this without charging you a fee to buy small allotments at a time. Many of these companies even let you reinvest dividends free of charge. These positions can become quite large after a while just from purchasing small amounts of stock at a time. Purchasing over time allows an investor to dollar-cost-average into a position.
HON HON VALU HON.WI GTX GTX.WI
The broad markets saw a massive drop this past week but posted a small recovery to close out the week. This drop off could offer a nice buying opportunity as the third-quarter earnings reporting season gets underway. 24/7 Wall St. has put together a preview of some of the major companies posting their quarterly results this week.
PM NFLX PYPL BAC HON KMI MS KMR CVB HON BAC SLB SYF UAL HON.WI TRI SCL SLB KMRFZ
2018-10-13 seekingalpha - 4
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
GLBS PERY PSX LCII ABT CRM SHPG CSCO MS AMC COF-P SMPL ISRG SYF DVMT IDA JNJ HON.WI MSFT HLUKF LEVL FTCH APHQF UTHR MTW ADS FB SCL NFLX AXP SKX SU BAC COF-D COF-C COF-F AAPL CCI ELAN HUBB CE SU EB SURF TRIP PVTL GSK EOG SIX JPM PATK SBUX CNTTF KMRFZ CNC CNK WMT NKE SHAK AMZN HON KMI TWTR HCSG GSK TRMB EAF KMR AA DXC CVB EBAY REGN SLB BAC DFS CRON STBA SC UAL GOOGL LTXB AHBIF PENN SCL SLB QCOM WFCNP XLNX PM PG PNK CPB PYPL VMW WGO TLRY USB GS MYL JEC SWI XYF WEED DXC.WI ECL ABT IBM CWH WFC HON BUD C TPR CMCSA THO COF BSVN LECO CGC SNY VLTHF V SCHW HP T MRK SNE DPZ
On Oct 12, we issued an updated research report on Honeywell International Inc. (HON - Free Report) . This Zacks Rank #3 (Hold) company is poised to grow on the back of stellar sales, new investments, greater operational efficacy and stronger liquidity. However, escalating cost remains a major cause of concern. Reflecting neutral analysts’ sentiments, the Zacks Consensus Estimate for the company’s earnings remained unchanged for both 2018 and 2019 over the past seven days.
HON CBSH CBSHP HON MIC AIN HON.WI UTX CBCB
United Technologies Corporation (UTX - Free Report) has announced that it is rewarding shareholders in the form of a hike in the quarterly dividend rate. We believe that such shareholder-friendly policies of the company reflect a strong cash position and its potential to improve profitability in the months ahead. As revealed, United Technologies’ board of directors approved 5% or 3.5 cents per share hike in the quarterly dividend rate, which moved from 70 cents to 73.
HON HON MIC HON.WI UTX DHR
Cognex (NASDAQ:CGNX), which operates in the internet of things (IoT) sector, has started October on a rough note, and investors should expect this weakness in CGNX stock to continue during this last quarter, especially around its earnings call. With that in mind, there are two bearish plays in CGNX that I want to share with you, as each play could lead to impressive profits.
HON FTV HON CGNX CAJ HON.WI KODK
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"[email protected],"!O8FH-/#PO3&EN96%R:7IE9" [email protected],S,T M-34O3R Q,2]%(#(X,S([email protected],B]4(#,S,[email protected]@6R [email protected],30Y73X^#65N M9&]B:@[email protected](" @(" @(" @(" @(" @(" @#0HQ-B P(&]B:@T\/"]$96-O9&50 M87)M7!E+UA2968O5ULQ(#(@,5T^/G-T('$UP8&)D:&&2 E#(Q,_QEW_P<(, "18 [email protected] M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')[email protected]*, T*)25%3T8-"B @(" @ M(" @#0HQ.2 P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22 X,R],96YG [email protected]@-S O4R T.
2018-10-09 reuters - 1
WASHINGTON (Reuters) - The U.S. Supreme Court on Tuesday turned aside appeals of a 2017 lower court ruling by its newest justice, Brett Kavanaugh, that struck down an environmental rule imposed under former President Barack Obama regulating a potent greenhouse gas linked to climate change.
HON AKE HON HON.WI ARKAF ARKAY
2018-10-09 investorplace - 1
Investors are rarely excited by the industrial sector. Unfortunately, when it comes to sheer performance in 2018, industrial ETFs are living up to that less-than-thrilling billing. As of Oct. 3rd, the Industrial Select Sector SPDR (NYSERCA:XLI), the largest industrial exchange traded fund (ETF) by assets, is up 6.5% year-to-date, well behind the 10.7% returned by the S&P 500.
HON GE GEC PRN PHO UTX HON BOE HON.WI GNE BA MMM
2018-10-05 zacks - 1
Honeywell International Inc. (HON - Free Report) has announced that a subsidiary of Resideo Technologies, Inc. (Resideo) — Resideo Funding Inc. — priced an offering of $400 million worth of senior notes due to mature on Nov 1, 2026. This offering is anticipated to close on Oct 19, 2018. It’s worth mentioning here that senior notes offering have been made in relation to the previously announced spin-off of Resideo from Honeywell.
HON HON FSS HON.WI REZI ITT DHR YY
The recruitment industry is witnessing a massive transformation as the implementation of robotics is speeding up hiring processes and making it efficient. According to a CNBC report, almost all Fortune 500 companies are using some variants of automation to pace up their recruitment procedure.
HON HON PEP BOE HON.WI ACN BA YY
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to HON / Honeywell International, Inc. on message board site Silicon Investor.
as of ET